Chiral nanomaterials as vaccine adjuvants: a new horizon in immunotherapy
Crossref DOI link: https://doi.org/10.1039/D4NR03542A
Published Online: 2025
Update policy: https://doi.org/10.1039/rsc_crossmark_policy
Wang, Kaixuan
Wang, Hongshuang
Wang, Xiaohui https://orcid.org/0000-0002-3415-5612
Funding for this research was provided by:
National Natural Science Foundation of China (T2350008, T2394502)
Chinese Academy of Sciences
Accepted Manuscript valid from 2025-12-11
